These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33986388)

  • 21. Efficacy and safety of sirolimus in lymphangioleiomyomatosis.
    McCormack FX; Inoue Y; Moss J; Singer LG; Strange C; Nakata K; Barker AF; Chapman JT; Brantly ML; Stocks JM; Brown KK; Lynch JP; Goldberg HJ; Young LR; Kinder BW; Downey GP; Sullivan EJ; Colby TV; McKay RT; Cohen MM; Korbee L; Taveira-DaSilva AM; Lee HS; Krischer JP; Trapnell BC; ;
    N Engl J Med; 2011 Apr; 364(17):1595-606. PubMed ID: 21410393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sirolimus decreases circulating lymphangioleiomyomatosis cells in patients with lymphangioleiomyomatosis.
    Cai X; Pacheco-Rodriguez G; Haughey M; Samsel L; Xu S; Wu HP; McCoy JP; Stylianou M; Darling TN; Moss J
    Chest; 2014 Jan; 145(1):108-112. PubMed ID: 24051985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of low-dose Sirolimus in Lymphangioleiomyomatosis.
    Yoon HY; Hwang JJ; Kim DS; Song JW
    Orphanet J Rare Dis; 2018 Nov; 13(1):204. PubMed ID: 30428897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis.
    Takada T; Mikami A; Kitamura N; Seyama K; Inoue Y; Nagai K; Suzuki M; Moriyama H; Akasaka K; Tazawa R; Hirai T; Mishima M; Hayashida M; Hirose M; Sugimoto C; Arai T; Hattori N; Watanabe K; Tamada T; Yoshizawa H; Akazawa K; Tanaka T; Yagi K; Young LR; McCormack FX; Nakata K
    Ann Am Thorac Soc; 2016 Nov; 13(11):1912-1922. PubMed ID: 27513278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional improvements in patients with lymphangioleiomyomatosis after sirolimus: an observational study.
    Zhan Y; Shen L; Xu W; Wu X; Zhang W; Wang J; Li X; Yang Y; Tian X; Xu KF
    Orphanet J Rare Dis; 2018 Feb; 13(1):34. PubMed ID: 29458386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
    Wang Q; Luo M; Xiang B; Chen S; Ji Y
    Respir Res; 2020 Feb; 21(1):55. PubMed ID: 32059669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
    Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
    Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term clinical course and outcomes in patients with lymphangioleiomyomatosis.
    Yoon HY; Kim HJ; Song JW
    Respir Res; 2022 Jun; 23(1):158. PubMed ID: 35717210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
    Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
    J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of CT Imaging to Quantify Progression and Response to Treatment in Lymphangioleiomyomatosis.
    Gopalakrishnan V; Yao J; Steagall WK; Avila NA; Taveira-DaSilva AM; Stylianou M; Chen MY; Moss J
    Chest; 2019 May; 155(5):962-971. PubMed ID: 30660784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Summaries for patients. Sirolimus therapy in patients with lymphangioleiomyomatosis.
    Ann Intern Med; 2011 Jun; 154(12):I44. PubMed ID: 21690578
    [No Abstract]   [Full Text] [Related]  

  • 32. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
    Lu C; Lee HS; Pappas GP; Dilling DF; Burger CD; Shifren A; Veeraraghavan S; Chapman JT; Parambil J; Ruoss SJ; Young LR; Hammes SR; Kopras EJ; Roads T; Krischer JP; McCormack FX;
    Ann Am Thorac Soc; 2017 Jun; 14(6):919-928. PubMed ID: 28570161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for stomatitis in patients with lymphangioleiomyomatosis during treatment with sirolimus: A multicenter investigator-initiated prospective study.
    Kitamura N; Seyama K; Inoue Y; Nagai K; Suzuki M; Moriyama H; Takada T; Tazawa R; Hirai T; Mishima M; Hayashida M; Hirose M; Arai T; Sugimoto C; Hattori N; Watanabe K; Tamada T; Akazawa K; Tanaka T; Nakata K
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1182-1189. PubMed ID: 28752672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective review of combined sirolimus and simvastatin therapy in lymphangioleiomyomatosis.
    Taveira-DaSilva AM; Jones AM; Julien-Williams PA; Stylianou M; Moss J
    Chest; 2015 Jan; 147(1):180-187. PubMed ID: 25167325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.
    Harari S; Elia D; Torre O; Bulgheroni E; Provasi E; Moss J
    Chest; 2016 Aug; 150(2):e29-32. PubMed ID: 27502989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in size of renal angiomyolipoma after treatment with everolimus in lung transplantation due to lymphangioleiomyomatosis.
    Bujalance-Cabrera C; Vaquero-Barrios JM; Redel-Montero J; Caballero-Ballesteros L; Requejo-Jiménez A; Santos-Luna F
    Arch Bronconeumol; 2012 Dec; 48(12):479-81. PubMed ID: 22444789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current management of lymphangioleiomyomatosis.
    Taillé C; Borie R; Crestani B
    Curr Opin Pulm Med; 2011 Sep; 17(5):374-8. PubMed ID: 21760507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent advances in the pathobiology and clinical management of lymphangioleiomyomatosis.
    Harari S; Spagnolo P; Cocconcelli E; Luisi F; Cottin V
    Curr Opin Pulm Med; 2018 Sep; 24(5):469-476. PubMed ID: 29927757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre.
    Baldi BG; Samano MN; Campos SV; de Oliveira MR; Junior JEA; Carraro RM; Teixeira RHOB; Minguini IP; Burlina R; Pato EZS; Carvalho CRR; Costa AN
    Lung; 2017 Dec; 195(6):699-705. PubMed ID: 28823029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
    Johnson J; Somerfield W; Johnson SR
    Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.